COVID-19
COVID: DMARDs, Steroids, a Vaccine - and how long will this continue? Dr. Winthrop Discusses
Dr. Kevin Winthrop reviews all things COVID-related including abstract L01, steroids and DMARDs, vaccination status - and how long this pandemic will last.
Outcomes of COVID in Rheumatic Disease Patients: Dr. Eric Dein
Dr. Eric Dein reviews abstract L01 presented at the 2020 ACR annual meeting.
How bad is COVID19 for rheumatic disease patients? Dr. Jeff Curtis
Dr. Jeffrey Curtis reviews abstract L01 presented Monday at the 2020 ACR annual meeting.
How COVID Changed Work: Drs. Rachel Tate, Cassie Calabrese and Mary Hinojos Mamut
Dr. Rachel Tate, Dr. Cassie Calabrese and Dr. Mary Hinojos Mamut discuss how COVID has changed patient care, work-life balance, adapting and triaging opportunities and activities, and more.
Prothrombotic Antiphospholipid Antibodies in COVID-19: Dr. David Liew
Dr. David Liew reviews abstract #0429 at the 2020 ACR annual meeting.
COVID 19 and Rheumatic Disease: Dr. Jeffrey Sparks
Dr. Jeffrey Sparks reviews COVID-19 related abstracts #0430 and L01 at the 2020 ACR annual meeting.
COVID and Rheumatic Disease Patients: Dr. Kevin Winthrop
Portland-based Dr. Kevin Winthrop from OHSU discusses Saturday ACR 2020 posters #0623 and #0629 related to COVID-19 and RA patients.
Outcomes for Rheumatic Disease Patients with COVID-19: Dr Kathryn Dao
Dr. Kathryn Dao discusses plenary abstract #0430 presented Friday at the ACR 2020 annual meeting.
Dr. Janet Pope interviews A&R Editor Dr. Daniel Solomon
Dr. Janet Pope interviews Arthritis & Rheumatology Editor Dr. Daniel Solomon about his role as editor, COVID-19 related submissions, and overall journal submissions
Race/ethnicity Associated with Poor Outcomes in Rheum Patients with COVID-19 : Dr. Dey
Dr. Mrinalini Dey discusses abstract #0006 presented Friday at the ACR 2020 annual meeting.
Poster Hall